Related Experiment Videos
Antagonism in action between mouse or human interferon and platelet growth factor
Archives of Virology
|January 1, 1980
Abstract:
Human leukocyte and mouse fibroblast interferons abolished the mitogenic effect of human or bovine platelet growth factor (PGF) on human or mouse cells. Conversely, the antiviral and anticellular activity of both forms of interferon was inhibited by PGF in the homologous and in certain heterologous cell systems.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Colostrinin: a proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study.
Archivum immunologiae et therapiae experimentalis·1999
Development and disappearance of tolerance to induction of interferon and tumor necrosis factor response in athletes treated with natural immunostimulant.
Archivum immunologiae et therapiae experimentalis·1999
Antifungal activity of 2-(4-chlorophenyl)-1,2-benzisoselenazol-3(2H)-one, the analog of Ebselen.
Archivum immunologiae et therapiae experimentalis·1999
[Selenium in health and disease].
Postepy higieny i medycyny doswiadczalnej·1998
Tumor-associated antigens are cytokine inducers and hyporeactivity factors to the immune system.
Biotherapy (Dordrecht, Netherlands)·1998
Modulation of cytokine production by a selenoorganic compound (AE-22) in hyperreactive or hyporeactive bronchoalveolar leukocytes of asthmatics or lung cancer patients.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·1997
Pyridin-3-carbohydrazide strongly impairs Mayaro and Chikungunya virus replication in vitro.
Archives of virology·2026
Complete Genome Sequence of Atractylodes virus A, a Novel Carlavirus Infecting Atractylodes lancea.
Archives of virology·2026
Extravascular distribution of factor IX-review of experimental and clinical evidence, and relevance for hemophilia B replacement therapy.
Research and practice in thrombosis and haemostasis·2026
Simultaneous targeting of IL-10 and PD-(L)1 pathways with a bispecific anti-PD-L1/IL-10-trap antibody enhances T cell responses.
Molecular therapy. Oncology·2026
SARS-CoV-2-induced IgG repertoires shape T cell responses, microRNA regulation, and autoreactivity according to disease severity.
Journal of translational autoimmunity·2026